---
schema_version: "secwatch.filing_event.v1"
accession: "0001323885-24-000013"
form_type: "8-K"
ticker: "ATRC"
cik: "0001323885"
company_name: "AtriCure, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T00:51:23.335584+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# AtriCure Q4 revenue $106.5M (+21%), full-year adj EBITDA positive $19.4M; guides 2024 rev ~$459-466M

## Summary
- Q4 2023 revenue $106.5M (+21% YoY); full-year revenue $399.2M (+20.8%).
- Full-year 2023 net loss improved $16M to $30.4M; adjusted EBITDA turned positive to $19.4M from -$2.2M.
- Full-year diluted net loss per share $0.66 vs $1.02 in 2022; adjusted loss per share $0.75 vs $1.02.
- 2024 revenue guidance $459-$466M (15-17% growth); adjusted EBITDA $26-$29M (34-49% increase).
- Over one million patients treated life to date; management cites broad-based expansion and momentum.

## SEC filing metadata
- accession: 0001323885-24-000013
- form_type: 8-K
- ticker: ATRC
- cik: 0001323885
- company_name: AtriCure, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000013/0001323885-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000013/atrc-20240215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001323885-24-000013
- JSON: https://secwatch.observer/filing/0001323885-24-000013.json
- Plain text: https://secwatch.observer/filing/0001323885-24-000013.txt

## Key facts
- Earnings Releases
  AtriCure, Inc. reported financial results for the fourth quarter and full-year ended December 31, 2023.
  - Period: the fourth quarter and full-year ended December 31, 2023
  - Result: reported results
  source text: On February 15, 2024 , AtriCure, Inc. issued a press release regarding its financial results for the fourth quarter and full-year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1323885/000132388524000013/0001323885-24-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.